← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
University Of Massachusetts Medical School
Worcester, MA
$122,321,937
Total funding
109
Grants
Funding over time
peak $17.9M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$94,558,802 · 60
NSF$22,078,255 · 42
DOE$3,963,359 · 4
USDA$1,663,599 · 2
NASA$57,922 · 1
By mechanism
—$122,321,937 · 109
Investigators at University Of Massachusetts Medical School
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
VECTORED DELIVERY OF OLIGOCLONAL ANTIBODIES FOR PROTECTION AGAINST ENTEROTOXIN MEDIATED DIARRHEAL DISEASES$11,411,276
· FY2013 · Department of Defense
ANTICIPATING INFLUENZA RESISTANCE EVOLUTION (AIRE): PATHWAYS AND STRATEGIES$9,982,624
· FY2015 · Department of Defense
ADVANCEMENT OF CRISPR-BASED ADIPOSE TISSUE THERAPIES FOR TYPE 2 DIABETES TO NONHUMAN PRIMATES$9,706,177
· FY2021 · Defense Health Agency
RNA-BASED STRATEGIES FOR PREVENTION AND TREATMENT OF ALPHAVIRUS AND HEMORRHAGIC FEVER VIRUS INFECTION$7,707,792
· FY2024 · Defense Health Agency
CRISPR-BASED ADIPOSE THERAPIES FOR ACCELERATED AGING IN IRRADIATED NONHUMAN PRIMATES.$5,712,429
· FY2025 · Defense Health Agency
TUNING OF PROGRAMMABLE PATHWAYS TO LIMIT EPIDEMICS OF INFLUENZA$4,709,460
· FY2019 · Department of the Navy
Frameworks-Imaging-PHD: Empowering data reuse and reproducibility through microscopy-community-defined Persistent Hardware Descriptors$3,999,550
· FY2025 · CSE
TARGETING HUMAN RESPIRATORY VIRUSES AND HOST SEQUENCES WITH RESPIRATORY-ACTIVE RNAS$3,854,000
· FY2025 · Defense Health Agency
BIODISTRIBUTION AND TOXICOLOGY ASSESSMENT OF GENE THERAPY FOR POST-OPERATIVE ATRIAL FIBRILLATION$2,566,849
· FY2016 · Department of the Army
DEVELOPMENT OF A NOVEL TARGETED RNAI DELIVERY TECHNOLOGY IN THERAPIES FOR METABOLIC DISEASES$2,324,484
· FY2015 · Department of Defense
COVID-19 EXPANSION FOR AIRE PROGRAM$1,994,324
· FY2021 · Defense Health Agency
NEW FY2009 CONSTRUCTION GRANT FOR BOSTON COLLEGE - PR # 09CH11573$1,849,542
· FY2009 · Department of Energy
ENGINEERED PROBIOTICS FOR FARM ANIMAL AND HUMAN NEMATODES$1,700,000
· FY2016 · National Institute of Food and Agriculture
RAPID PRECLINICAL DEVELOPMENT OF A NOVEL ORAL MEDICINE FOR PREVENTION AND TREATMENT OF ENTEROTOXIGENIC ESCHERICHIA COLI DIARRHEAL DISEASE.$1,539,634
· FY2021 · Defense Health Agency
CRISPR-BASED GENE EDITING TO INDUCE THERMOGENIC ADIPOSE TISSUE IN TYPE 2 DIABETES$1,496,424
· FY2018 · Department of the Army
SYNTHETIC LECTINS: NEW TOOL FOR DETECTION AND MANAGEMENT OF PROSTATE CANCER.$1,485,000
· FY2012 · Department of Defense
MATHEMATICAL MODELING AND SYNTHETIC BIOLOGY TO DISCOVER NEW ESBL-PE-ERADICATING MICROBIOME-BASED THERAPEUTICS$1,426,556
· FY2020 · Defense Health Agency
DETERMINING MECHANISTIC LINKS BETWEEN TRAUMATIC BRAIN INJURY, STRESS RESPONSE, AND NEURODEGENERATION.$1,299,997
· FY2020 · Defense Health Agency
SULFORAPHANE TREATMENT OF CHILDREN WITH AUTISM SPECTRUM DISORDER$1,260,906
· FY2015 · Department of Defense
TARGETING THE GENETIC DETERMINANTS OF IMMUNE ESCAPE AND IMMUNOTHERAPY FAILURE IN CRPC$1,247,724
· FY2022 · Defense Health Agency